220 related articles for article (PubMed ID: 37190581)
1. The Relevance of Serum Macrophage Migration Inhibitory Factor Level and Executive Function in Patients with White Matter Hyperintensity in Cerebral Small Vessel Disease.
Zhao J; Wang X; Yu M; Zhang S; Li Q; Liu H; Zhang J; Cai R; Lu C; Li S
Brain Sci; 2023 Apr; 13(4):. PubMed ID: 37190581
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of White Matter Hyperintensity and Cognitive Impairment in Patients with Acute Lacunar Stroke.
Ye M; Zhou Y; Chen H; Zhu S; Diao S; Zhao J; Kong Y; Li T
Brain Sci; 2022 Dec; 12(12):. PubMed ID: 36552134
[TBL] [Abstract][Full Text] [Related]
3. White matter hyperintensities combined with serum NLRP3 in diagnosis of cognitive impairment in patients with cerebral small vessel disease.
Huang R; Zhang L; Deng L; Chen C
Scand J Clin Lab Invest; 2023 Nov; 83(7):448-454. PubMed ID: 37702579
[No Abstract] [Full Text] [Related]
4. Macrophage Migration Inhibitory Factor as a Potential Plasma Biomarker of Cognitive Impairment in Cerebral Small Vessel Disease.
Shi Y; Deng J; Mao H; Han Y; Gao Q; Zeng S; Ma L; Ji W; Li Y; Xi G; Li L; You Y; Shao J; Chen K; Fang X; Wang F
ACS Omega; 2024 Apr; 9(13):15339-15349. PubMed ID: 38585104
[TBL] [Abstract][Full Text] [Related]
5. Impaired functional network properties contribute to white matter hyperintensity related cognitive decline in patients with cerebral small vessel disease.
Wang Y; Liu X; Hu Y; Yu Z; Wu T; Wang J; Liu J; Liu J
BMC Med Imaging; 2022 Mar; 22(1):40. PubMed ID: 35264145
[TBL] [Abstract][Full Text] [Related]
6. Value of white matter hyperintensity volume and total white matter volume for evaluating cognitive impairment in patients with cerebral small-vessel disease.
Zhang S; Hu Y; Yang H; Li Q; Chen J; Bai H
Front Aging Neurosci; 2023; 15():1096808. PubMed ID: 37065461
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of White Matter Hyperintensities in Cognitively Impaired Patients With Cerebral Small Vessel Disease.
Wang T; Jin A; Fu Y; Zhang Z; Li S; Wang D; Wang Y
Front Immunol; 2021; 12():803504. PubMed ID: 34956241
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Cerebral Blood Flow Measured by 3D PCASL as Biomarker of Vascular Cognitive Impairment and Dementia (VCID) in a Cohort of Elderly Latinx Subjects at Risk of Small Vessel Disease.
Jann K; Shao X; Ma SJ; Cen SY; D'Orazio L; Barisano G; Yan L; Casey M; Lamas J; Staffaroni AM; Kramer JH; Ringman JM; Wang DJJ
Front Neurosci; 2021; 15():627627. PubMed ID: 33584191
[TBL] [Abstract][Full Text] [Related]
9. Electroencephalographic power spectrum changes in cerebral small vessel disease combined with cognitive dysfunction and its relationship with neutrophil/lymphocyte ratio and its clinical value - a pilot study.
Guo X; Liu Z; Yuan W; Wei A; Luo G
Front Neurol; 2023; 14():1300240. PubMed ID: 38283675
[TBL] [Abstract][Full Text] [Related]
10. Arteriolosclerosis CSVD: a common cause of dementia and stroke and its association with cognitive function and total MRI burden.
Hua M; Ma AJ; Liu ZQ; Ji LL; Zhang J; Xu YF; Chen WY; Mao LL
Front Aging Neurosci; 2023; 15():1163349. PubMed ID: 37520130
[TBL] [Abstract][Full Text] [Related]
11. Serum Cortisol Is Associated With Cerebral Small Vessel Disease-Related Brain Changes and Cognitive Impairment.
Qiu Q; Zhou X; Wu L; Zhang Y; Yu Z; Wang M; Huang H; Luo X; Pan D
Front Aging Neurosci; 2021; 13():809684. PubMed ID: 35126094
[TBL] [Abstract][Full Text] [Related]
12. Impact of White Matter Hyperintensity and Age on Gait Parameters in Patients With Cerebral Small Vessel Disease.
Jiang M; Wu S; Zhang Y; Li Y; Lin B; Pan Q; Tian S; Ni R; Liu Q; Zhu Y
J Am Med Dir Assoc; 2023 May; 24(5):672-678. PubMed ID: 36592938
[TBL] [Abstract][Full Text] [Related]
13. Hippocampal amide proton transfer values are associated with cerebral small vessel disease imaging markers and total burden: a community-based cross-sectional study.
Mu R; Qin X; Zheng W; Yang P; Huang B; Li X; Liu F; Deng K; Zhu X
Quant Imaging Med Surg; 2024 Mar; 14(3):2603-2613. PubMed ID: 38545036
[TBL] [Abstract][Full Text] [Related]
14. The correlation between the severity of cerebral microbleeds and serum HMGB1 levels and cognitive impairment in patients with cerebral small vessel disease.
Wang M; Liu J; Wang F; Li Q; Zhang J; Ji S; Li S; Lu C; Zhao J
Front Aging Neurosci; 2023; 15():1221548. PubMed ID: 37424630
[TBL] [Abstract][Full Text] [Related]
15. Total Cerebral Small Vessel Disease Burden on MRI Correlates With Medial Temporal Lobe Atrophy and Cognitive Performance in Patients of a Memory Clinic.
Fan Y; Shen M; Huo Y; Gao X; Li C; Zheng R; Zhang J
Front Aging Neurosci; 2021; 13():698035. PubMed ID: 34566621
[No Abstract] [Full Text] [Related]
16. Neuropsychological Profile of Early Cognitive Impairment in Cerebral Small Vessel Disease.
Seki M; Yoshizawa H; Hosoya M; Kitagawa K
Cerebrovasc Dis; 2022; 51(5):600-607. PubMed ID: 35378532
[TBL] [Abstract][Full Text] [Related]
17. Negative correlation between serum pyruvate kinase M2 and cognitive function in patients with cerebral small vessel disease.
Bian L; Zhou Y; Zhang D; Jiang T; Xing C; Wu X; Wang T; Zhu X
Clin Neurol Neurosurg; 2023 Feb; 225():107586. PubMed ID: 36641992
[TBL] [Abstract][Full Text] [Related]
18. Cerebral Small Vessel Disease is Associated with Mild Cognitive Impairment in Type 2 Diabetes Mellitus.
Teng Z; Feng J; Liu R; Dong Y; Chen H; Xu J; Jiang X; Li R; Lv P
Diabetes Metab Syndr Obes; 2022; 15():1985-1994. PubMed ID: 35814027
[TBL] [Abstract][Full Text] [Related]
19. Correlation of blood pressure levels at different time periods throughout the day with total CSVD burden and MRI imaging markers.
Yang H; Fan X; Shen X; Liang L; Hu D; Zhang Y; Liu L; Qian H
Front Neurol; 2023; 14():1200846. PubMed ID: 37576008
[TBL] [Abstract][Full Text] [Related]
20. Relevance of cerebral small vessel disease load scores in first-ever lacunar infarction.
Tang R; Liu Z
Clin Neurol Neurosurg; 2021 Jan; 200():106368. PubMed ID: 33260085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
